Clinical Trials Browser

Unknown × tipifarnib × Clear all

NCT02535650 2022-03-08

Study of Tipifarnib in Patients With Previously-Treated, Advanced, HRAS Mutant Urothelial Carcinoma

Phase 2 Unknown

Carcinoma, Transitional Cell

NCT00510939 2009-08-14

HEMOS AML 0106

Phase 2 Unknown

Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Acute

NCT00006199 2005-06-24

Study of the Farnesyl Transferase Inhibitor, R115777, in Combination With Topotecan (NYU 99-32)

Phase 1 Unknown

Neoplasms